Abstract:Prions are proteins that can adopt at least 2 distinct conformations (structural states), being one of them soluble, either natively folded or intrinsically disordered, and the other an aggregated fibrillar structure, termed amyloid, made of stacked ß-strands contributed by the individual protein molecules [1]. Amyloids propagate their conformation to soluble protein molecules of their same kind by contact, capturing them as new building blocks of their elongating fibers. Conformational variants (i.e., alternative 3D folds for the same protein sequence) of an amyloid assembly can be propagated as distinct prion strains vertically with cell division, from mother to daughter cells, for many generations constituting a case for cytoplasmatic, non-mendelian epigenetic inheritance [1]. After the pioneering discovery of the mammalian prion protein PrP [2], the whole field was boosted by findings in the yeast Saccharomyces cerevisiae , in which several transcriptional and translational factors (such as Sup35 and Ure2) were shown to aggregate as amyloids, resulting in loss-of-function phenotypes ([ PSI + ] and [ URE3 ], respectively) [3,4]. Alternative strains of yeast prions were horizontally transmissible between cells while mating through cytoduction (i.e., cytoplasmatic mixing) [5]. In yeast, depending on the protein, its amyloid state either elicits a functionally adaptive phenotypic change or becomes cytotoxic and deleterious [6,7]. Horizontal transmission as an infectious agent has been recently described also for amyloid proteins involved in human neurodegenerative diseases such α-synuclein, Tau, the ß-amyloid peptides, and TDP-43, self-propagating as prion-like proteins (or prionoids) between cells within different areas of the central nervous system [8]. In bacteria, as exemplified by the Escherichia coli biofilm scaffolding protein CsgA, some extracellular secreted proteins rely on a complex, dedicated protein machinery for their regulated assembly as functional amyloids, with defined fibrillar structures and physiological roles [9]. These are distinct to prions, in which the soluble monomers are functional while the amyloid fibrils that they assemble, usually polymorphic, lose that function [8]. Mining in prokaryotic proteomes identified many proteins with potential prion forming domains (PrDs), typically intrinsically disordered (IDPs) and with overall polar residue composition, similar to those in yeast prions [10,11]. However, so far detailed experimental characterization of bacterial prions is restricted to individual domains in just 3 proteins adopting an amyloid state (Fig 1).

A Protein Misfolding Shaking Amplification-based method for the spontaneous generation of hundreds of bona fide prions

Development of a methodology for large-scale production of prions for biological and structural studies

Protein Misfolding Cyclic Amplification Cross-Species Products of Mouse-Adapted Scrapie Strain 139A and Hamster-Adapted Scrapie Strain 263K with Brain and Muscle Tissues of Opposite Animals Generate Infectious Prions

Glycoform-independent prion conversion by highly efficient, cell-based, protein misfolding cyclic amplification

Understanding Intra-Species and Inter-Species Prion Conversion and Zoonotic Potential Using Protein Misfolding Cyclic Amplification

Probing the origin of prion protein misfolding via reconstruction of ancestral proteins

PrP(Sc) of Scrapie 263K Propagates Efficiently in Spleen and Muscle Tissues with Protein Misfolding Cyclic Amplification.

Species barrier as molecular basis for adaptation of synthetic prions with N‐terminally truncated PrP

Spontaneous generation of distinct prion variants with recombinant prion protein from a baculovirus-insect cell expression system

Convergent generation of atypical prions in knockin mouse models of genetic prion disease

Prions and protein-folding diseases

Comparison of the Unfolding and Oligomerization of Human Prion Protein under Acidic and Neutral Environments by Molecular Dynamics Simulations

The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases

Structural and dynamical determinants of a β-sheet-enriched intermediate involved in amyloid fibrillar assembly of human prion protein

Prion assemblies: structural heterogeneity, mechanisms of formation, and role in species barrier

From Seeds to Fibrils and Back: Fragmentation as an Overlooked Step in the Propagation of Prions and Prion-Like Proteins

The importance of prion research

Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseases

Protein Misfolding Cyclic Amplification and Its Application

The emergence of bacterial prions

Unfolding Mechanism and Fibril Formation Propensity of Human Prion Protein in the Presence of Molecular Crowding Agents